Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
We Can Medicines CoROCO:6929 -0.45%46 EV-to-FCF is 9.42 as of Jul. 14, 2026, which is 37% below its 10-year median of 15.05. GuruFocus rates ROCO:6929 with a GF Score™ of 46/100 and a GF Value™ of NT$40.73 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,188 Consumer Packaged Goods companies, We Can Medicines Co ranks better than 70.45% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, We Can Medicines Co's Enterprise Value is NT$1,922 Mil.
We Can Medicines Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$204 Mil. Therefore, We Can Medicines Co's EV-to-FCF for today is 9.42.
The historical rank and industry rank for We Can Medicines Co's EV-to-FCF or its related term are showing as below:
ROCO:6929'
s EV-to-FCF Range Over the Past 10 Years
Min: -106.87 Med: 15.05 Max: 558.44
Current: 9.44
During the past 6 years, the highest EV-to-FCF of We Can Medicines Co was 558.44. The lowest was -106.87. And the median was 15.05.
ROCO:6929's EV-to-FCF is ranked better than 70.45% of 1188
companies
in the Consumer Packaged Goods industry
Industry Median: 15.85
vs ROCO:6929: 9.44
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
We Can Medicines Co (ROCO:6929) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
We Can Medicines Co's PE Ratio (TTM) for today is calculated as:
We Can Medicines Co's share price for today is NT$22.30.
We Can Medicines Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-1.630.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
We Can Medicines Co EV-to-FCF Related Terms
We Can Medicines Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for We Can Medicines Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, We Can Medicines Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
We Can Medicines Co EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where We Can Medicines Co's EV-to-FCF falls into.
We Can Medicines Co's current Enterprise Value is NT$1,922 Mil.
We Can Medicines Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$204 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
We Can Medicines Co (ROCO:6929) has a EV-to-FCF of 9.42 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on We Can Medicines Co and its competitors. This is 37% below median its historical median of 15.05. According to the industry distribution chart, We Can Medicines Co ranks #351 out of 1188 companies in the Consumer Packaged Goods industry, placing it in the top 29.5%.
Is We Can Medicines Co's EV-to-FCF too high?
We Can Medicines Co's current EV-to-FCF of 9.42 is 37% below median its 10-year median of 15.05. The Consumer Packaged Goods industry median EV-to-FCF is 15.85. We Can Medicines Co's value of 9.42 is 40.6% below this industry median. Based on the distribution chart, We Can Medicines Co ranks #351 out of 1188 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, We Can Medicines Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does We Can Medicines Co's EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, We Can Medicines Co ranks #351 out of 1188 companies for EV-to-FCF. This puts We Can Medicines Co in the upper half of its industry. The industry median EV-to-FCF is 15.85. We Can Medicines Co's value of 9.42 is 40.6% below this benchmark. While the company's 10-year median is 15.05 vs. the industry median of 15.85, We Can Medicines Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.85, based on 1,188 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. We Can Medicines Co's current EV-to-FCF of 9.42 is 40.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on We Can Medicines Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. We Can Medicines Co's current EV-to-FCF is 9.42, which is 37% below median its own 10-year median of 15.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is We Can Medicines Co stock overvalued right now?
Based on GuruFocus' analysis, We Can Medicines Co (ROCO:6929) is currently considered Possible Value Trap. The stock's GF Value™ is NT$40.73, compared to a current price of NT$22.30 — trading 45.2% below its estimated fair value. The current EV-to-FCF is 9.42, which is 37% below median its 10-year median of 15.05 and 40.6% below the Consumer Packaged Goods industry median of 15.85. We Can Medicines Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For We Can Medicines Co (ROCO:6929), the current EV-to-FCF is 9.42 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is We Can Medicines Co (ROCO:6929) Overvalued in 2026?
Based on GuruFocus' analysis, We Can Medicines Co stock appears to be undervalued.
The current stock price of NT$22.30 is trading 45.2% below its estimated GF Value™ of NT$40.73.
GuruFocus considers We Can Medicines Co to be Possible Value Trap.
Key valuation signals for ROCO:6929:
EV-to-FCF: 9.42 (37% below median its 10-year median of 15.05)
GF Value™: NT$40.73 vs. price of NT$22.30 (45.2% below fair value)
Industry Position: 40.6% below the Consumer Packaged Goods median (#351 of 1188)
No single metric tells the full story. See the ROCO:6929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
46GF Score
Get the complete analysis for ROCO:6929
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6929 has been successfully added to your 
